Atlas Trials

Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study

Clinical trial NCT03640884 · UNKNOWN

Trial details

NCT number
NCT03640884
Sponsor
Zhong Wang
Status
UNKNOWN
Study type
OBSERVATIONAL
Adverse Drug EventAdverse Drug ReactionsAnaphylactic ReactionSevere Adverse Reactions
Start date
2019-02-18
Primary completion
2021-12-01
Enrollment
30000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.